New "Basket" Studies
Dr. David Hyman, a cancer specialist at Memorial Sloan Kettering, said:
This is really a new breed of study. Conventional therapy might give a response rate of 10 or 20 percent. The newer drug has a response rate of 50 or 60 percent. Does it make sense to do a randomized trial? When you are having a big effect, it is kind of jaw dropping. These are response rates we haven’t seen before in diseases.
"Match" -- the Basket of All Baskets
Will the FDA Support Basket Study Results?